Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.00%
)
US TECH 100
29,044.80
(
1.20%
)
Dow Jones
50,579.70
(
0.00%
)
Brent Oil
96.01
(
-5.11%
)
Bitcoin
77,050.90
(
-0.28%
)
News Focus
News Focus
Post# of 518780
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27892
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: XenaLives post# 331507

Thursday, 09/30/2021 5:48:35 AM

Thursday, September 30, 2021 5:48:35 AM

Post# of 518780
I agree.

Anavex is not facing any uphill work or cost for marketing, sales or partnership deals should one or more of their compounds gain approval in rare diseases.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News